Phylogenetic Analysis of Antigenic Variability in Klebsiella pneumoniae against Antibacterial Ocular Drugs
Keywords:
Antigenic variability, Class-A beta-lactamase, Klebsiella pneumonia, Ocular drugs, Phylogeny.Abstract
Klebsiella pneumonia, associated with significant proportion of hospital-acquired urinary tract infections, pneumonia, soft tissue infections, liver abscess, endophthalmitis and meningitis. Though the antibiotic eye drops against K. pneumoniae are available, immunologically distinct strains evolved by mutations in epitopes and leads resistance to ocular antibacterial drugs. The analysis of escape mutation necessitates new drug development.Also, it constitutes a major challenge to effective drug design. In present work, molecular basis of antigenic resistance in K. pneumoniae against the antibacterial ocular drugs was investigated. The resistance genes were identified and identified that genetic drift was found in 16 genes and higher number of mutaionswas found in class-A beta-lactamase.The protein sequences of class-A beta-lactamase from resistance strains were obtained and antigenic variability was carried out in terms of antigenic distance based on the sequence alignment and phylogenetic analysis. Moreover the docking study of protein with drug molecules was done in order to find out whether the mutations are at active site or at other residues.It was found that, mutations were dispersed throughout the sequence, and were not found at a particular segment. The escape mutation was found less at active site than rest. It concludes that the mutations in non-active residues may leads to changes in electrostatic and steric interactions. In this work, drift was analyzed in class-A beta-lactamase alone, the overall analysis may play potential role in effective designing of antibacterial drug against K. pneumoniae.
Keywords: Antigenic variability, Class-A beta-lactamase, Klebsiella pneumonia, ocular drugs, phylogeny
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |